R21, a novel particle based vaccine for a multi-component approach to malaria vaccination
<p>Malaria is a major cause of mortality and morbidity and an effective vaccine is an urgent global health priority. This thesis evaluates the liver stage viral vector regimen ChAd63 – MVA ME.TRAP in humans and demonstrates the induction of partial protective efficacy (21%) against sporozoite...
Main Author: | Collins, K |
---|---|
Other Authors: | Hill, A |
Format: | Thesis |
Published: |
2014
|
Similar Items
-
R21 vaccine: A ray of hope for malaria elimination
by: Nitika Nitika, et al.
Published: (2023-01-01) -
The R21 malaria vaccine: Spotlight on policy goals and pathways to African vaccine manufacturing
by: Olusoji Adeyi, et al.
Published: (2024-01-01) -
Pre-erythrocytic malaria vaccines: RTS,S, R21, and beyond
by: Elizabeth Adrianne Hammershaimb, et al.
Published: (2024-12-01) -
Roll out and prospects of the malaria vaccine R21/Matrix-M.
by: Lorenz von Seidlein
Published: (2025-01-01) -
R21/Matrix-M™ malaria vaccine: A realm of hope for combating malaria in developing countries?
by: Kanza Farhan, et al.
Published: (2024-08-01)